The guidance of a health care professional and patient-specific considerations, i.e
Z.WarringtonJ.et al
Brand-name tirzepatide escalation (Mounjaro/Zepbound schedule) Notice the optional tiers at 7.5 mg and 12.5 mg
The clinical principle is to titrate antihypertensives downward as weight loss progresses, not to discontinue abruptly
Answer No, at this moment, we are working on a solution however are not ready to implement at this time Q: Where can I find my order payment instructions
In the future, with the in-depth exploration of the mechanism of GLP-1R action and the development of multi-target agonists (e.g., GLP-1R/GIPR dual agonists), GLP-1R-related therapeutics are expected to make breakthroughs in a wider range of disease areas (e.g., nonalcoholic steatohepatitis, AD, etc.), providing a more precise and highly effective strategy for the treatment of metabolic diseases and related complications